Selective binding of lectins to normal and neoplastic urothelium in rat and mouse bladder carcinogenesis models

Protoplasma

Volumn 251, Issue 1, 2014, Pages 49-59

  Zupančič, Daša ^a   Kreft, Mateja Erdani ^a   Romih, Rok ^a  

^a Institute of Cell Biology   (Slovenia)

Author keywords

Carcinogenesis; Lectins; Scanning electron microscopy; Urinary bladder; Uroplakins; Urothelium

Indexed keywords

AMARANTHUS CAUDATUS; ANIMALIA; ARTOCARPUS HETEROPHYLLUS; DATURA STRAMONIUM; MUS; RATTUS;

LECTIN;

ANIMAL; ARTICLE; BINDING SITE; BLADDER; BLADDER TUMOR; CARCINOGENESIS; DISEASE MODEL; FLUORESCENT ANTIBODY TECHNIQUE; MALE; METABOLISM; MOUSE; PATHOLOGY; PROTEIN BINDING; RAT; SCANNING ELECTRON MICROSCOPY; STAINING; ULTRASTRUCTURE; UROTHELIUM; WISTAR RAT;

ANIMALS; BINDING SITES; CARCINOGENESIS; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; LECTINS; MALE; MICE; MICROSCOPY, ELECTRON, SCANNING; PROTEIN BINDING; RATS; RATS, WISTAR; STAINING AND LABELING; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84892538927     PISSN: 0033183X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00709-013-0524-9     Document Type: Article

References (43)

1. Arai M, Kani T, Sugihara S, Matsumura K, Miyata Y, Shinohara Y, Ito N (1974) Scanning and transmission electron microscopy of changes in the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Gann 65: 529-540.
2. Ariel I, Ayesh S, Gofrit O, Ayesh B, Abdul-Ghani R, Pizov G, Smith Y, Sidi AA, Birman T, Schneider T, de Groot N, Hochberg A (2004) Gene expression in the bladder carcinoma rat model. Mol Carcinog 41: 69-76.
3. Baldus SE, Hanisch FG, Monaca E, Karsten UR, Zirbes TK, Thiele J, Dienes HP (1999) Immunoreactivity of Thomsen-Friedenreich (TF) antigen in human neoplasms: the importance of carrier-specific glycotope expression on MUC1. Histol Histopathol 14: 1153-1158.
4. Cao Y, Stosiek P, Springer GF, Karsten U (1996) Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study. Histochem Cell Biol 106: 197-207.
5. Eble JN, Sauter G, Epstein J, Sesterhenn IA (2004) World Health Organization classification of tumours: tumours of the urinary system and male genital organs. IARC, Lyon.
6. Farokhzad OC, Dimitrakov JD, Karp JM, Khademhosseini A, Freeman MR, Langer R (2006) Drug delivery systems in urology-getting "smarter". Urology 68: 463-469.
7. Gasion JPB, Cruz JFJ (2006) Improving efficacy of intravesical chemotherapy. Eur Urol 50: 225-234.
8. Gofrit ON, Birman T, Dinaburg A, Ayesh S, Ohana P, Hochberg A (2006) Chemically induced bladder cancer-a sonographic and morphological description. Urology 68: 231-235.
9. He Z, Kosinska W, Zhao ZL, Wu XR, Guttenplan JB (2012) Tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine as the basis for urothelial carcinogenesis. Mutat Res 742: 92-95.
10. Hicks RM, Ketterer B (1969) Hexagonal lattice of subunits in the thick luminal membrane of the rat urinary bladder. Nature 224: 1304-1305.
11. Huang HY, Shariat SF, Sun TT, Lepor H, Shapiro E, Hsieh JT, Ashfaq R, Lotan Y, Wu XR (2007) Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumors progression and clinical outcome. Hum Pathol 38: 1703-1713.
12. Ito N (1976) Early changes caused by N-butyl-N-(4-hydroxybutyl)nitrosamine in the bladder epithelium of different animal species. Cancer Res 36: 2528-2531.
13. Jacobs JB, Arai M, Cohen SM, Friedell GH (1976) Early lesions in experimental bladder cancer: scanning electron microscopy of cell surface markers. Cancer Res 36: 2512-2517.
14. Kachar B, Liang F, Lins U, Ding M, Wu XR, Stoffler D, Aebi U, Sun TT (1999) Three-dimensional analysis of the 16 nm urothelial plaque particle: luminal surface exposure, preferential head-to-head interaction, and hinge formation. J Mol Biol 285: 595-608.
15. Koss LG (1969) The asymmetric unit membranes of the epithelium of the urinary bladder of the rat. An electron microscopic study of a mechanism of epithelial maturation and function. Lab Invest 21: 154-168.
16. Kreft ME, Robenek H (2012) Freeze-fracture replica immunolabelling reveals urothelial plaques in cultured urothelial cells. PLoS One 7(6): e38509.
17. Kreft ME, Romih R, Sterle M (2002) Antigenic and ultrastructural markers associated with urothelial cytodifferentiation in primary explant outgrowths of mouse bladder. Cell Biol Int 26: 63-74.
18. Kreft ME, Romih R, Kreft M, Jezernik K (2009) Endocytotic activity of bladder superficial urothelial cells is inversely related to their differentiation stage. Differentiation 77: 48-59.
19. Kreplak L, Wang H, Aebi U, Kong XP (2007) Atomic force microscopy of mammalian urothelial surface. J Mol Biol 374: 365-373.
20. Kunze E, Schauer A (1977) Morphology classification, and histogenesis of N-butyl-N-(4-hydroxybutyl)nitrosamine in rats. Z Krebsforsch Klin Onkol Cancer Res 88: 273-289.
21. Malagolini N, Cavallone D, Wu XR, Serafini-Cessi F (2000) Terminal glycosylation of bovine uroplakin III, one of the major integral-membrane glycoprotein of mammalian bladder. Biochim Biophys Acta 1475: 231-237.
22. Neal DE, Charlton RG, Bennett MK (1987) Histochemical study of lectin binding in neoplastic and non-neoplastic urothelium. Br J Urol 60: 399-404.
23. Neutsch L, Plattner VE, Polster-Wildhofen S, Zidar S, Chott A, Borchard G, Zechner O, Gabor F, Wirth M (2011) Lectin mediated biorecognition as a novel strategy for targeted delivery to bladder cancer. J Urol 186: 1481-1488.
24. Ogawa K, St John M, Luiza de Oliveira M, Arnold L, Shirai T, Sun TT, Cohen SM (1999) Comparison of uroplakin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats and mice. Toxicol Pathol 27: 645-651.
25. Ohyama C (2008) Glycosylation in bladder cancer. Int J Clin Oncol 13: 308-313.
26. Parker SL, Tong T, Bolden S, Wingo PA (1997) Cancer statistic CA. Cancer J Clin 47: 5-27.
27. Parkin DM, Whelan SL, Ferlay L, Teppo L, Thomas DB (2002) Cancer incidence in five continents. IAEC Sci Publ 155: 1-773.
28. Plattner VE, Wagner M, Ratzinger G, Gabor F, Wirth M (2008) Targeted drug delivery: binding and uptake of plant lectins using human 5637 bladder cancer cells. Eur J Pharm Biopharm 70: 572-576.
29. Ploeg M, Aben KKH, Kiemeney LA (2009) The present and future burden of urinary bladder cancer in the world. World J Urol 27: 289-293.
30. Recker F, Otto T, Rübben H (1992) Lectins in diagnosis of bladder carcinoma. Urol Int 48: 149-153.
31. Romih R, Jezernik K (1996) Reorganization of the urothelial luminal plasma membrane in the cyclophosphamide treated rats. Pflugers Arch Suppl 431: R241-R242.
32. Romih R, Veranic P, Jezernik K (2002) Appraisal of differentiation markers in urothelial cells. Appl Immunohistochem Mol Morphol 10: 339-343.
33. Schenk-Braat EA, Bangma CH (2005) Immunotherapy for superficial bladder cancer. Cancer Immunol Immunother 54: 414-423.
34. Sharon N, Lis H (1972) Lectins: cell-agglutinating and sugar-specific proteins. Science 177(4053): 949-959.
35. Shen Z, Shen T, Wientjes MG, ÓDonnell MA, Au JL-S (2008) Intravesical treatments of bladder cancer: review. Pharm Res 25: 1500-1510.
36. Vasconcelos-Nóbrega C, Colaço A, Lopes C, Oliveira PA (2012) Review: BBN as an urothelial carcinogen. In Vivo 26: 727-739.
37. Wu XR, Sun TT (1993) Molecular cloning of a 47 kDa tissue-specific and differentiation-dependent urothelial cell glycoprotein. J Cell Sci 106: 31-43.
38. Wu XR, Manabe M, Yu J, Sun TT (1990) Large scale purification and immunolocalisation of bovine uroplakins I, II, and III. Molecular markers of urothelial differentiation. J Biol Chem 265: 1775-1784.
39. Wu XR, Lin JH, Walz T, Häner M, Yu J, Aebi U, Sun TT (1994) Mammalian uroplakins. A group of highly conserved urothelial different ion-related membrane proteins. J Biol Chem 269: 13716-13724.
40. Xie B, Zhou G, Chan SY, Shapiro E, Kong XP, Wu XR, Sun TT, Costello CE (2006) Distinct glycan structures of uroplakins Ia and Ib. J Biol Chem 281: 14644-14653.
41. Yu J, Lin JH, Wu XR, Sun TT (1994) Uroplakins Ia and Ib, two major different ion products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins. J Cell Biol 125: 171-182.
42. Yu LG, Milton JD, Fernig DG, Rhodes JM (2001) Opposite effects on human colon cancer cell proliferation of two dietary Thomsen-Friedenreich antigen-binding lectins. J Cell Physiol 186: 282-287.
43. Zupančič D, Ovčak Z, Vidmar G, Romih R (2011) Altered expression of UPIa, UPIb, UPII, and UPIIIa during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats. Virchows Arch 458: 603-613.